tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Revenue

Compare
303 Followers

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had a revenue of 23.19M in the quarter ending Jun 30, 2025, with -72.69%. This bring the company's revenue in the last twelve months to 177.99M, Decreased 11.60%. In the fiscal year ending Dec 31, 2024, Monte Rosa Therapeutics had annual revenue of 75.62M with Infinity% growth.
Revenue (ttm)
177.99M
Revenue Growth
2990.57%
P/S Ratio
3.94
Revenue/Employee
$532,549
Employees
142
Market Cap
$297.68M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
75.62M+∞%
Dec 31, 2023
0.00
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis